ARUP Labs
Despite Broad Carve-Outs, FDA Final Rule on LDTs Draws Critical Response From Lab Industry
The rule makes explicit that LDTs are subject to FDA oversight but provides for enforcement discretion across a broad range of tests.
In Brief This Week: Centogene, ARUP Laboratories, Oxford Nanopore, GenTegra, More
News items for the week of Nov. 27, 2023
Researchers from Japan, Israel, and US demonstrated the large-scale implementation of rapid whole-genome sequencing in NICUs.
Lack of Standardization Across MDx Infectious Disease Tests Could Undermine Pandemic Preparedness
Premium
Poor cross-compatibility may make it difficult to substitute components of automated sample processing and testing workflows in the case of shortages.
ARUP hopes to use TellBio's platform for several applications in solid tumor types, including prostate and gynecological cancers.
Sep 8, 2016
IDbyDNA Raises $9M in Series A Financing Round
Aug 25, 2016
Apr 2, 2013
Arup to Offer Predictive Bio's Bladder Cancer Dx
Mar 18, 2013